BDF-521 is a chemical compound that has garnered attention in the field of bioactive compounds, specifically as a potential therapeutic agent. It is known as a selective inhibitor of the protein Bcl-2, which plays a crucial role in regulating apoptosis (programmed cell death). BDF-521 may be studied for its implications in cancer treatment, particularly in cases where Bcl-2 overexpression is associated with resistance to chemotherapy.
New to topics? Read the docs here!